Figure 2From: Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 monthsHaematology and biochemical safety parameters. Line with filled squares show children vaccinated with 15 μg MSP3, filled circles show children vaccinated with 30 μg MSP3 and filled triangles show children vaccinated with Engerix B. Error bars show 95% confidence interval.Back to article page